Zobrazeno 1 - 10
of 701
pro vyhledávání: '"G, Ferraccioli"'
Autor:
M. Rossini, O. Viapiana, M. Vitiello, N. Malavolta, G. La Montagna, S. Maddali Bongi, O. Di Munno, R. Nuti, C.U. Manzini, C. Ferri, L. Bogliolo, A. Mathieu, F. Cantatore, A. Del Puente, M. Muratore, W. Grassi, B. Frediani, G. Saviola, P. Delvino, L. Mirone, G. Ferraccioli, G. Tripi, I. Piazza, D. Gatti
Publikováno v:
Reumatismo, Vol 69, Iss 1, Pp 30-39 (2017)
Osteoporosis and fractures are common and invalidating consequences of chronic glucorticoid (GC) treatment. Reliable information regarding the epidemiology of GC induced osteoporosis (GIOP) comes exclusively from the placebo group of randomized clini
Externí odkaz:
https://doaj.org/article/f717f6764b0642069eeb137985402106
Autor:
G. Lapadula, A. Marchesoni, F. Salaffi, R. Ramonda, C. Salvarani, L. Punzi, L. Costa, F. Caso, D. Simone, G. Baiocchi, C. Scioscia, M. Di Carlo, R. Scarpa, G. Ferraccioli
Publikováno v:
Reumatismo, Vol 68, Iss 3, Pp 126-136 (2016)
Psoriatic arthritis (PsA) is a chronic inflammatory disease involving skin, peripheral joints, entheses, and axial skeleton. The disease is frequently associated with extrarticular manifestations (EAMs) and comorbidities. In order to create a protoco
Externí odkaz:
https://doaj.org/article/6f022e9eaa0744db900aed036a89508c
Autor:
S. Ramiro, R. B. M. Landewé, D. Van der Heijde, A. Sepriano, O. Fitzgerald, M. Østergaard, J. Homik, O. Elkayam, C. Thorne, M. Larché, G. Ferraccioli, M. Backhaus, G. Boire, B. Combe, T. Schaeverbeke, A. Saraux, M. Dougados, M. Rossini, M. Govoni, L. Sinigaglia, A. Cantagrel, C. Allaart, C. Barnabe, C. Bingham, D. Van Schaardenburg, H. B. Hammer, R. Dadashova, E. Hutchings, J. Paschke, W. P. Maksymowych
Publikováno v:
Annals of the Rheumatic Diseases. 81:279-281
BackgroundA Treat-to-Target approach (T2T) is broadly considered to lead to better clinical outcomes and recommended in patients with RA. However, very few studies have analyzed the effect of T2T on radiographic progression, and any such studies have
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b2e125d51931f7fc5aacd09549ef1fdf
https://doi.org/10.1136/annrheumdis-2022-eular.2161
https://doi.org/10.1136/annrheumdis-2022-eular.2161
Publikováno v:
Reumatismo, Vol 64, Iss 6, Pp 368-373 (2012)
Objective. Several studies underline the relevance of the genetic background for the response to therapy. We evaluated the relationship between the polymorphism of the HS1,2A enhancer, located in the 3’ regulatory region of the heavy immunoglobulin
Externí odkaz:
https://doaj.org/article/bb08af493f5d4ac3b4d7ff3265b561a4
Publikováno v:
Reumatismo, Vol 63, Iss 3, Pp 155-164 (2011)
The GISEA registry is an independent database that was established by the Italian Group for the Study of Early Arthritis (GISEA) in 2008, funded by the Italian Association of Rheumatic Patients (ANMAR - ONLUS). In line with the network’s epidemiolo
Externí odkaz:
https://doaj.org/article/d52f8a11a320480b958d17cb4a98f03b
Publikováno v:
Reumatismo, Vol 60, Iss 2, Pp 85-94 (2011)
Rheumatoid arthritis (RA) is a chronic inflammatory disease characterized by synovial inflammation and pannus formation, which can lead to severe destruction of cartilage and bone. Several self proteins have been suggested to be disease-driving autoa
Externí odkaz:
https://doaj.org/article/8aa6d30d2a4d4844872b5332fc21357a
Autor:
G. Ferraccioli
Publikováno v:
Reumatismo, Vol 57, Iss 4s, Pp 17-21 (2011)
Objective: To evaluate the efficacy, the tolerability, and treatment survival of the association of anti-TNFa (Infliximab, Etanercept, Adalimumab) plus Methotrexate vs Methotrexate as monotherapy in patients with reumathoid arthritis (RA). Methods: R
Externí odkaz:
https://doaj.org/article/2516d25a01294618a8be1c441336b64d
Autor:
G. Ferraccioli
Publikováno v:
Reumatismo, Vol 56, Iss 1s, Pp 46-50 (2011)
Several recent clinical studies have clearly established that rheumatoid arthritis (RA) is a disease identifiable since its early phases, a disease that can be adequately and efficaciously treated provided the therapeutic program can be started early
Externí odkaz:
https://doaj.org/article/995b65d71b4642548831ccf95d20fc3b
Autor:
M. Fornaro, F. Franceschini, E. Gremese, A. Cauli, M. Sebastiani, C. Montecucco, F. Conti, M. Rossini, R. Foti, F. P. Cantatore, E. Fusaro, C. Lomater, B. Frediani, M. Govoni, F. Atzeni, R. Ramonda, S. D’angelo, G. Ferraccioli, G. Lapadula, R. Caporali, F. Iannone
Publikováno v:
Annals of the Rheumatic Diseases. 81:585-586
BackgroundIn real-life setting, a greater number of elderly rheumatoid arthritis (RA) patients with impaired glomerular filtration rate (GFR) needs treatment with biologic or target synthetic disease-modifying anti-rheumatic drugs (b/tsDMARD) to achi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4eccbb27bd340ddab1c019ca62d62e5c
https://doi.org/10.1136/annrheumdis-2022-eular.5130
https://doi.org/10.1136/annrheumdis-2022-eular.5130
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.